Services

As a dedicated CRO, we specialize in oligonucleotide drug development, providing end-to-end solutions that encompass design, synthesis, purification, and characterization of oligonucleotides. Our state-of-the-art facilities are equipped with advanced chemistry and analytical technologies, enabling us to deliver high-quality oligonucleotides tailored to specific therapeutic needs. We collaborate closely with clients to streamline the development process, ensuring that each project meets its unique goals and timelines.

Our CDMO services offer comprehensive manufacturing solutions for oligonucleotide drugs. From preclinical to commercial-scale production, our facilities adhere to strict quality standards and regulatory guidelines. We utilize scalable processes that ensure consistency and reliability, whether the requirement is for small batches or large-scale manufacturing. Our team of experts is dedicated to optimizing production efficiency while minimizing costs, ensuring that your therapeutic candidates reach the market promptly.

Understanding regulatory requirements is critical for the successful commercialization of pharmaceuticals. Our regulatory support services guide clients through every stage of the regulatory process, including IND applications, filing for NDA approvals, and compliance with international guidelines. Our experienced regulatory affairs team stays abreast of the evolving landscape, providing strategic insights and ensuring that documentation meets the highest standards. This commitment minimizes delays and accelerates the pathway to market for clients.